DK0596326T3 - Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes and their salts, drugs containing the compounds and the use of the compounds, and process for the preparation of the compounds - Google Patents
Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes and their salts, drugs containing the compounds and the use of the compounds, and process for the preparation of the compoundsInfo
- Publication number
- DK0596326T3 DK0596326T3 DK93116959.3T DK93116959T DK0596326T3 DK 0596326 T3 DK0596326 T3 DK 0596326T3 DK 93116959 T DK93116959 T DK 93116959T DK 0596326 T3 DK0596326 T3 DK 0596326T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- azacycloalkanes
- arylidene
- arylalkyl
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ink Jet (AREA)
- Developing Agents For Electrophotography (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Catalysts (AREA)
Abstract
The invention relates to arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes of the general formula <IMAGE> in which n, m, p, A, W<1>, W<2>, X, Y and R<1> to R<11> are defined as in Claim 1, their isomers and isomer mixtures and their salts, which have useful properties and in particular exert an inhibitory action on cholesterol biosynthesis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4235590A DE4235590A1 (en) | 1992-10-22 | 1992-10-22 | Arylidene-1-aza:cycloalkane derivs. - are inhibitors of cholesterol biosynthesis and hence useful in treating hyper-cholesterolaemia and atherosclerosis. |
DE4303840A DE4303840A1 (en) | 1992-10-22 | 1993-02-10 | Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0596326T3 true DK0596326T3 (en) | 1996-01-15 |
Family
ID=25919689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93116959.3T DK0596326T3 (en) | 1992-10-22 | 1993-10-20 | Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes and their salts, drugs containing the compounds and the use of the compounds, and process for the preparation of the compounds |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0596326B1 (en) |
JP (1) | JP3396517B2 (en) |
KR (1) | KR100306520B1 (en) |
CN (1) | CN1040873C (en) |
AT (1) | ATE126797T1 (en) |
AU (1) | AU665648B2 (en) |
CA (1) | CA2108817C (en) |
CZ (1) | CZ286025B6 (en) |
DE (2) | DE4303840A1 (en) |
DK (1) | DK0596326T3 (en) |
ES (1) | ES2078787T3 (en) |
FI (1) | FI934665A (en) |
GR (1) | GR3017692T3 (en) |
HK (1) | HK1000285A1 (en) |
HU (1) | HU221630B1 (en) |
IL (1) | IL107342A (en) |
NO (1) | NO300843B1 (en) |
NZ (1) | NZ250018A (en) |
PL (1) | PL173775B1 (en) |
RU (1) | RU2126400C1 (en) |
SK (1) | SK281222B6 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4234295A1 (en) * | 1992-10-12 | 1994-04-14 | Thomae Gmbh Dr K | Carboxylic acid derivatives, medicaments containing these compounds and process for their preparation |
IL110943A (en) * | 1994-09-13 | 1997-02-18 | Univ Ramot | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders |
DE19754795A1 (en) * | 1997-12-10 | 1999-06-17 | Boehringer Ingelheim Pharma | New urethanes, their thio and dithio analogues, their salts, medicines containing them and their use, and processes for their preparation |
AU5227999A (en) * | 1998-07-27 | 2000-02-21 | Abbott Laboratories | Substituted oxazolines as antiproliferative agents |
US6228868B1 (en) | 1998-07-27 | 2001-05-08 | Abbott Laboratories | Oxazoline antiproliferative agents |
EP1499306A4 (en) | 2002-04-12 | 2007-03-28 | Merck & Co Inc | Bicyclic amides |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863932A (en) * | 1988-03-11 | 1989-09-05 | Somatogenetics International, Inc. | Squalene oxide cyclase inhibitors and therapeutic use thereof |
CA2025490C (en) * | 1989-09-22 | 2003-09-16 | James R. Mccarthy | Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
CA2047375C (en) * | 1990-07-25 | 2003-04-15 | Charlotte L. Barney | Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis |
US5084461A (en) * | 1991-03-27 | 1992-01-28 | Merrell Dow Pharmaceuticals Inc. | Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis |
-
1993
- 1993-02-10 DE DE4303840A patent/DE4303840A1/en not_active Ceased
- 1993-10-05 SK SK1073-93A patent/SK281222B6/en unknown
- 1993-10-20 CA CA002108817A patent/CA2108817C/en not_active Expired - Fee Related
- 1993-10-20 DE DE59300507T patent/DE59300507D1/en not_active Expired - Lifetime
- 1993-10-20 DK DK93116959.3T patent/DK0596326T3/en active
- 1993-10-20 AT AT93116959T patent/ATE126797T1/en active
- 1993-10-20 EP EP93116959A patent/EP0596326B1/en not_active Expired - Lifetime
- 1993-10-20 ES ES93116959T patent/ES2078787T3/en not_active Expired - Lifetime
- 1993-10-21 KR KR1019930021923A patent/KR100306520B1/en not_active IP Right Cessation
- 1993-10-21 RU RU93048154/04A patent/RU2126400C1/en not_active IP Right Cessation
- 1993-10-21 NZ NZ250018A patent/NZ250018A/en unknown
- 1993-10-21 IL IL107342A patent/IL107342A/en not_active IP Right Cessation
- 1993-10-21 AU AU49135/93A patent/AU665648B2/en not_active Ceased
- 1993-10-21 JP JP26321493A patent/JP3396517B2/en not_active Expired - Fee Related
- 1993-10-21 HU HU9302986A patent/HU221630B1/en not_active IP Right Cessation
- 1993-10-21 NO NO933790A patent/NO300843B1/en not_active IP Right Cessation
- 1993-10-22 CN CN93119156A patent/CN1040873C/en not_active Expired - Fee Related
- 1993-10-22 PL PL93300834A patent/PL173775B1/en unknown
- 1993-10-22 FI FI934665A patent/FI934665A/en unknown
- 1993-10-22 CZ CZ932236A patent/CZ286025B6/en not_active IP Right Cessation
-
1995
- 1995-10-11 GR GR950402801T patent/GR3017692T3/en unknown
-
1997
- 1997-09-26 HK HK97101852A patent/HK1000285A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0530087T3 (en) | New Naphthylethylurea and Naphthylethylthiourea Compounds, Methods of Preparation and Pharmaceutical Agents Containing Them | |
DK0513543T3 (en) | Amidinophenylalanine derivatives, processes for their preparation, their use and anticoagulants containing them | |
NO302884B1 (en) | Crystalline 3,4,4-trisubstituted-piperidinyl-N-alkyl carboxylates and intermediates, process for preparing the crystalline carboxylates, pharmaceutical compositions containing them and their use | |
DK0659174T3 (en) | Derivatives of valproic acid and 2-valproic acid amides as well as their use as anticonvulsants | |
DK0618190T3 (en) | 9- (Substituted glycyl) amido-6- (substituted) -5-hydroxy-6-deoxy-tetracyclines | |
MX9304756A (en) | 9 - [(SUBSTITUTED GLYCLE) AMIDO] -6-DESMETIL-6-DESOXITETRACICLINAS, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
DK0612322T3 (en) | Process for Separation of 5-Methyl-Tetrahydrofolic Acid | |
DK0404283T3 (en) | 11alpha-aryl-4-estrenes, processes for their preparation and their use as pharmaceuticals | |
DK0532515T3 (en) | Preparation of substituted piperidines | |
NZ228065A (en) | 1,2,4-triazinediones and parasiticidal compositions; processes for preparation | |
DK243989A (en) | RING-SUBSTITUTED 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENES, PROCEDURE FOR PREPARING SUCH COMPOUNDS AND PHARMACEUTICALS CONTAINING THESE | |
DK0596326T3 (en) | Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes and their salts, drugs containing the compounds and the use of the compounds, and process for the preparation of the compounds | |
DK0553016T3 (en) | New Naphthalenamides and Sulfonamides, Methods for their Preparation, and Pharmaceutical Agents Containing Them | |
ATE113628T1 (en) | AMMONIUM COMPOUND, THE COMPOSITION CONTAINED THIS AND DISINFECTION METHOD. | |
SE8102047L (en) | INHIBITORS OF CHOLESTEROL BIOSYNTHESIS, THEIR PREPARATION AND USE | |
ITMI911853A1 (en) | SALT OF DICLOFENAC, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT. | |
ES2062214T3 (en) | DERIVATIVES OF AMINOOLIGOHIDROXI RENINA INHIBITORS. | |
BR9100488A (en) | PROCESS FOR THE PREPARATION OF COMPOUNDS, COMPOSITION FOR COMBATING OR INHIBITING AN INFESTATION BY MICROORGANISMS | |
NO305556B1 (en) | Thiocarbamoyl compounds and their use as well as means for protecting technical materials | |
DK0611755T3 (en) | New (cyclohexyl) alkene compounds, processes for their preparation and pharmaceutical agents containing them | |
HN1993199340A (en) | N- (4,6 DIME) AMIN - 3 - TRI - 2 - SULFO OR ONE OF ITS USEFUL SALTS HERBED COMPOSITION CONTAINING THE SAME AND PROCESS FOR THE PRODUCTION OF THE COMPOUNDS. |